Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Winner winner chicken dinner! Thank you for all your contributions to the board!
Endoluminal ie similar time Auris monarch and the ISRG endoluminal. McNally mentioned future endoluminal capabilities with ENOS if so it only increases the value. Auris Monarch sold for 3.5 billion roughly.
Send him a private message. if no one else is allowed to answer your post. Otherwise don’t post your question on a public board. Now on Monday nurse you should ScoopEm!
No logical reason that the pps should have ever been at these levels to begin with. Heavily shorted and now they cover.
No move up continues imo.
Warrants were exercised 15m. It’s on Edgar.
You are so desperate. Hilarious.
There is no such thing as a sure thing. Could be a number of reasons for a R/S. I didn’t like it either. Voted against it.
Probably best to look forward because like it not the platform is progressing. Other outside events could also speed things up from a B/O perspective. Anyway hope it speeds up and we leave these levels in the rear view mirror.
So the up is building on itself. Essentially the IP began with specific components . What we are beginning to see now is IP covering the “system” as a whole not just specific parts and pieces. So yes it’s pretty important to see a patent like the “robotic surgery system” patent that was just published.
I like what I’m seeing especially the pps movement.
I wonder if the licensing deal is more or less an escrow payment or deposit by MDT??
You didn’t see the other two patents??
Have you done any sp cases?
Agree 100%. Single access point, no external moving arms give much more room for tech to assist. Huge advantage over other platforms. Having a assistant also reduces cognitive load on surgeon.
less is more.
Theoretically that would be a nice to have but in reality a surgeon only has to hands so having a bedside assistant retract may be preferable to clutching between a second and third arm. In this case there is room for a human to assist. In CMR, transenterix, Hugo case it would be more challenging to squeeze in between the pods.
Also keep in mind there are no moving arms external to the patient during the procedure. CMR davinci all have a great deal of movement. CMR transensterix and mdt Hugo all create a obstacle course of sorts that completely surround the patient many times from all sides. In that regard the footprint of a single Cary with no external moving arms is a huge advantage. Davinci XI has a single cart but all the arms dangle over top of the patient which certainly impedes access to the patient.
Titans platform is smallest and creates less hurdles/obstacles around the patient in regards to all aspects of the case. Look at the images of “real cases” by CMR posted on social media. Wires cables and pods all over the place
Check out the images of the CMR pods all around the patient with wires and cables all over the place. I don’t see any advantage to CMR re foot print. It’s pretty much a clusterF with all those pods.
You can absolutely use multiple tips on the the same snake for the same case. Snakes will have to be sterilized between cases.
You can look it up it’s in a year end filing but you’ll have to dig it up. Also McNally is happy to confirm it for you if you ask.
IREP license expired. I confirmed this a few years ago. Essentially IREP was academic “know how” not unlike the raven platform from university of Washington. Titan utilized the “know how” to develop sport and now ENOS. The tech involved in ENOS far supercedes IREP and that license was discontinued. Notably IREP ip was never granted either.
Not sure about that since you have to really look deep into the ip filing to find the assignment. And not all of the recent awards are assigned to covidien.
At this point it appears not to matter too much to Mcnally to support the plight of shareholders. They have 12 months of cash and no need to do a raise in the near future therefore no need to prop up the share price?
Or they know that future milestones may hold great value so no need to scrap for nickels at this point??
No one saw the license with MDT coming so who knows what happens next. Can only wait I suppose.
Every patent Is important. They should PR everyone of them. Cost to Pr isn’t that much. Also this one isn’t assigned to covidien unlike some of the other IP.
More important is that Mcnally keeps to his word about being more transparent to shareholders. So far it’s the same playbook.
This isn’t the first IP for titan with haptic feedback. They have a couple.
Look at the articulated instrumentation slide. https://titanmedicalinc.com/technology/#instruments
Perhaps you are confusing wristed with rotation.
Sorry but what you are saying is incorrect. Isrg sp operates in the manner you describe.
Tips of the snakes rotate. Titan has IP on this and has demonstrated the rotation of the tips in multiple videos.
Yep that’s why our pps sucks. Must be ENOS.
Opinions are like ENOS’s everybody’s got one. I like it actually.
He’s shorter than a polar bear’s pecker in the middle of January.
66% fidelity
77% interactive brokers.
I do wish!! You don’t lol??
Sachin likely assisting with a marketing plan for ENOS/HUGO. Too early in the relationship to be stealing employees. This was consensual no doubt about it.
HIYA short19
1 month ago.
Sachin has gone to work for Medtronic robotic surgery. Who is next? Hopefully the whole company in a buyout!
Illegal you say. Too funny.
The primary investors in hedge funds are institutional investors. These are professional investors who manage large amounts of cash. They work for pension funds for corporations, government workers, and labor unions. They also manage sovereign wealth funds for entire countries. They handle the cash assets of insurance companies, corporations, and trust funds. Institutional investors provide 65 percent of the capital invested in hedge funds.
No way to know especially if a third party bought on behalf of another party.
Agm is Sept 30.
Oh and copy Geoff Martha for full effect lol.
I suggest emailing David Mcnally. They are delinquent per TSX guidelines in providing notice to shareholders via Press release. Should have received at latest yesterday.
Can’t post a working link for sedar. Just go to sedar.com enter titan medical in search. It was filed july 30.
?? It is scheduled for sept 30 per sedar.